Pimco Corporate (PCN) 15.20 $PCN PIMCO Closed-End Funds

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Pimco Corporate (PCN) 15.20 $PCN

PIMCO Closed-End Funds Declare Monthly Common Share Distributions
Marketwired - Fri Jul 01, 3:47PM CDT
NEW YORK, NY--(Marketwired - Jul 1, 2016) - The Boards of Trustees/Directors of the PIMCO closed-end funds (each, a "Fund" and, collectively, the "Funds" have declared a monthly distribution for each Fund's common shares as summarized below. The distributions are payable on August 1, 2016 to shareholders of record on July 11, 2016, with an ex-dividend date of July 7, 2016.
PDI: 27.67 (-0.27), PCI: 19.57 (+0.04), PTY: 14.23 (-0.11), PCK: 10.52 (-0.19), PML: 13.91 (-0.10), PCM: 9.78 (+0.05), PCN: 15.20 (-0.48), RCS: 9.87 (+0.10), PCQ: 16.83 (-0.26), PMF: 16.70 (-0.30), PYN: 11.46 (-0.37), PFN: 9.34 (unch), PZC: 12.39 (-0.16), PGP: 20.26 (unch), PNI: 14.30 (-0.19), PNF: 13.99 (-0.27), PKO: 23.23 (+0.05), PMX: 12.74 (-0.07), PHK: 9.80 (-0.07), PFL: 10.53 (+0.05)

PIMCO Closed-End Funds Declare Special Year-End Distributions
Marketwired - Fri Dec 11, 3:30PM CST
The Boards of Trustees/Directors of the PIMCO closed-end funds (each, a "Fund" and, collectively, the "Funds" have declared a special year-end distribution for each Fund's common shares as summarized below. The distributions are payable on December 29, 2015 to shareholders of record on December 21, 2015, with an ex-dividend date of December 17, 2015. In addition to the regular monthly dividend, this special year-end distribution is being paid to allow the Funds to meet their 2015 distribution requirements for federal excise tax purposes. The Funds' total distribution will be taxable to shareholders in 2015.
PFN: 9.34 (unch), PDI: 27.67 (-0.27), PCI: 19.57 (+0.04), PKO: 23.23 (+0.05), PTY: 14.23 (-0.11), PCN: 15.20 (-0.48), RCS: 9.87 (+0.10)

Downtrend Call Working As PIMCO Corporate Income Fund Stock Falls 12.9% (PCN)
Comtex SmarTrend(R) - Fri Nov 27, 2:06PM CST
SmarTrend identified a Downtrend for PIMCO Corporate Income Fund (NYSECN) on September 26th, 2014 at $15.99. In approximately 14 months, PIMCO Corporate Income Fund has returned 12.86% as of today's recent price of $13.93.
PCN: 15.20 (-0.48)

PIMCO High Income Fund and PIMCO Corporate & Income Strategy Fund Announce Final Results of Tender Offers for Auction Rate Preferred Shares
Marketwired - Fri Nov 20, 5:53PM CST
PIMCO High Income Fund (NYSE: PHK) and PIMCO Corporate & Income Strategy Fund (NYSE: PCN) (each, a "Fund" and, together, the "Funds" today announced the expiration and final results for their issuer tender offers (each, a "Tender Offer" and, together, the "Tender Offers" for up to 100% of each Fund's outstanding auction rate preferred shares ("ARPS" at a price equal to 83%, with respect to PHK, and 82.5%, with respect to PCN, of the ARPS' per share liquidation preference of $25,000 per share (or $20,750 per share for PHK and $20,625 per share for PCN) and any unpaid dividends accrued through the expiration date of the Tender Offers. The Funds' Tender Offers expired on November 20, 2015 at 5:00 p.m. New York City time. All ARPS that were validly tendered and not withdrawn during the offering period have been accepted for payment.
PCN: 15.20 (-0.48), PHK: 9.80 (-0.07)

PIMCO Corporate Income Fund Has Returned 16.5% Since SmarTrend Recommendation (PCN)
Comtex SmarTrend(R) - Fri Nov 20, 9:39AM CST
SmarTrend identified a Downtrend for PIMCO Corporate Income Fund (NYSECN) on September 26th, 2014 at $15.99. In approximately 14 months, PIMCO Corporate Income Fund has returned 16.55% as of today's recent price of $13.34.
PCN: 15.20 (-0.48)

PIMCO Corporate Income Fund Shares Down 13.9% Since SmarTrend's Sell Call (PCN)
Comtex SmarTrend(R) - Thu Oct 22, 10:30AM CDT
SmarTrend identified a Downtrend for PIMCO Corporate Income Fund (NYSECN) on September 26th, 2014 at $15.99. In approximately 13 months, PIMCO Corporate Income Fund has returned 13.92% as of today's recent price of $13.76.
PCN: 15.20 (-0.48)

PIMCO High Income Fund and PIMCO Corporate & Income Strategy Fund Announce Tender Offers for Auction Rate Preferred Shares
Marketwired - Fri Oct 16, 3:35PM CDT
PIMCO High Income Fund (NYSE: PHK) and PIMCO Corporate & Income Strategy Fund (NYSE: PCN) (each, a "Fund" and, together, the "Funds" today announced that each Fund will commence a voluntary tender offer on or about October 16, 2015 (each, a "Tender Offer" and, together, the "Tender Offers" for up to 100% of its outstanding auction rate preferred shares ("ARPS" at a price equal to 83%, with respect to PHK, and 82.5%, with respect to PCN, of the ARPS' per share liquidation preference of $25,000 per share (or $20,750 per share for PHK and $20,625 per share for PCN) and any unpaid dividends accrued through the expiration date of the Tender Offer.
DB: 14.10 (+0.80), PCN: 15.20 (-0.48), PHK: 9.80 (-0.07)

Shares of PCN Down 15.6% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Wed Oct 07, 5:06PM CDT
SmarTrend identified a Downtrend for PIMCO Corporate Income Fund (NYSECN) on September 26th, 2014 at $15.99. In approximately 13 months, PIMCO Corporate Income Fund has returned 15.60% as of today's recent price of $13.49.
PCN: 15.20 (-0.48)

Update - PIMCO Closed-End Funds Declare Monthly Common Share Distributions
Marketwired - Fri Oct 02, 3:30PM CDT
The Boards of Trustees/Directors of the PIMCO closed-end funds (each, a "Fund" and, collectively, the "Funds" have declared a monthly distribution for each Fund's common shares as summarized below. The distributions are payable on November 2, 2015 to shareholders of record on October 12, 2015, with an ex-dividend date of October 7, 2015.
PDI: 27.67 (-0.27), PCI: 19.57 (+0.04), PTY: 14.23 (-0.11), PCK: 10.52 (-0.19), PML: 13.91 (-0.10), PCM: 9.78 (+0.05), PCN: 15.20 (-0.48), RCS: 9.87 (+0.10), PCQ: 16.83 (-0.26), PMF: 16.70 (-0.30), PYN: 11.46 (-0.37), PFN: 9.34 (unch), PZC: 12.39 (-0.16), PGP: 20.26 (unch), PNI: 14.30 (-0.19), PNF: 13.99 (-0.27), PKO: 23.23 (+0.05), PMX: 12.74 (-0.07), PHK: 9.80 (-0.07), PFL: 10.53 (+0.05)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 41

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 36

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 32

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 26

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 37

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Growth of Middle-Class Investors through Mutual Fund Ownership

Updated Category News Views 149

Mutual Funds and the Rise of the Middle-Class Investor Over recent years, mutual fund ownership has surged among middle-class families. According to insights from the Investment Company Institute (ICI), this trend signifies a vital transition as middle-income households increasingly seek investment opportunities. The growing presence of mutual funds in the American...

Continue Reading
Rques Exchange Reinforces Its Brand with Compliance Strategy

Updated Category News Views 180

Rques Exchange Reinforces Brand with Regulatory Frameworks Rques Exchange is taking significant steps to enhance its brand by emphasizing its commitment to regulatory alignment, operational transparency, and governance integrity in various markets. With global authorities increasingly scrutinizing digital asset platforms, Rques aims to position itself as a technology...

Continue Reading
Business Growth and Confidence: Provident Bank's Insights

Updated Category News Views 120

Increasing Business Confidence for the Future Recently, Provident Bank, a prominent financial institution based in New Jersey, conducted an enlightening Economic Outlook survey. This survey reflects the sentiments of 1,000 business leaders regarding the 2025 economic prospects. The results showcase a robust sense of optimism and confidence among businesses as they look...

Continue Reading
Performance Food Group Co: A Five-Year Stock Journey

Updated Category News Views 219

Unlocking the Value of Investment in Performance Food Group Co Performance Food Group Co (NYSE: PFGC) has delivered impressive returns over the last five years, standing out in the competitive market landscape. With an annualized return that has surpassed the market by 9.42%, investors have seen an average growth rate of around 24.5%. This stock is not just another entry...

Continue Reading
Understanding Rathbones Group Plc's Disclosure Requirements

Updated Category News Views 227

Key Information on Disclosure Requirements Understanding how companies disclose their shareholding is crucial for investors and stakeholders alike. Rathbones Group Plc plays an essential role in managing these disclosures, particularly regarding relevant securities that represent substantial interests in listed companies. Full Name of the Discloser The full name of the...

Continue Reading